Abraham earned his Ph.D. in 1976 from the Mt. Sinai School of Medicine in New York City. He spent his postdoctoral fellowship at Rockefeller University, where he discovered and isolated the rat and human heme oxygenase gene responsible for the over-production of bilirubin in newborn infants, which manifests as jaundice. In early 1982, he developed inhibitors of heme oxygenase for the prevention of jaundice with his mentor Dr. A. Kappas, former vice president of Rockefeller University and physician-in-chief. In 1977, he became an associate scientist at New York Medical College in New York. He initiated the college’s first program project on heme oxygenase in 1985.
Pharmacology
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
